We have seen this kind of moral failure before, in the response to the HIV pandemic, where the gap between rich and poor treatment lagged by more than a decade.
The COVID-19 Vaccines Global Access initiative, COVAX, led by WHO, GAVI and UNICEF was created to ensure that mistake was not repeated.
Launched in April 2020, it's an international initiative comprised of governments, health organizations, businesses, civil society and philanthropists working to ensure equitable access to COVID-19 vaccines.
Yet although COVAX has distributed more than 951 million vaccines, rich country hoarding, chronic under-investment, along with supply challenges have stopped it from doing all that it could.
UNDP is committed to working closely with the UN family and partners to ensure everybody receives a COVID-19 vaccine as quickly as possible. Not only is it the right thing to do, it also makes economic sense.
Vaccine inequity is undermining recovery. It could cost an already damaged world economy up to US$1.2 trillion a year—or enough to provide basic social protection and health care to all.
Overall it’s estimated the pandemic could cost US$9.2 trillion.
UNDP is working to ensure that vaccines are not the preserve of a privileged minority.
We work with The Global Fund to prepare countries for crises such as the COVID-19 pandemic.